Suchergebnisse - (Person:"Liu, Binliang")

PubPharm (5)

1

Exploring the clinical outcomes and safety profile of inetetamab treatment in metastatic breast cancer patients : A multicenter assessment of a Chinese-origin recombinant Anti-HER2 monoclonal antibody

enthalten in: Breast (Edinburgh, Scotland) | 2023

von Liu, B. | Xie, N. | Tian, C. | +16

2

The circulating tumor DNA (ctDNA) alteration level predicts therapeutic response in metastatic breast cancer : Novel prognostic indexes based on ctDNA

enthalten in: Breast (Edinburgh, Scotland) | 2022

von Liu, B. | Hu, Z. | Ran, J. | +4

3

Genome-wide chromosomal instability by cell-free DNA sequencing predicts survival in patients with metastatic breast cancer

enthalten in: Breast (Edinburgh, Scotland) | 2020

von Mo, H. | Wang, X. | Ma, F. | +7

4

Safety and efficacy of sirolimus combined with endocrine therapy in patients with advanced hormone receptor-positive breast cancer and the exploration of biomarkers

enthalten in: Breast (Edinburgh, Scotland) | 2020

von Yi, Z. | Liu, B. | Sun, X. | +10

5

Longitudinal HER2 amplification tracked in circulating tumor DNA for therapeutic effect monitoring and prognostic evaluation in patients with breast cancer

enthalten in: Breast (Edinburgh, Scotland) | 2020

von Guan, X. | Liu, B. | Niu, Y. | +9

1
[1]